Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06464341 · ClinicalTrials.gov registry record
Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study
A clinical trial, sponsored by University Hospital, Basel, Switzerland.
- Completed
- Registry status
- 583
- Enrollment target
NCT06464341 is a clinical trial that has completed, run by University Hospital, Basel, Switzerland. The registered enrollment target is 583 participants.
The verdict
NCT06464341 has completed, sponsored by University Hospital, Basel, Switzerland.
- COMPLETED
- Registry status
- 583 participants
- Enrollment target
Study Summary
The purposes of this multicenter retrospective cohort study are to determine the residual nodal burden in patients with isolated tumor cells detected in the SLN or the clipped node after NAC and to determine oncologic outcomes in this group of patients after ALND or nodal RT or observation.
Interventions
- OTHER Observational study no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 583 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06464341
The ClinicalTrials.gov registry entry for NCT06464341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 583 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospital, Basel, Switzerland, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational study no intervention is the first listed.
NCT06464341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06464341 about?
NCT06464341 is a clinical study titled "Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study". The purposes of this multicenter retrospective cohort study are to determine the residual nodal burden in patients with isolated tumor cells detected in the SLN or the clipped node after NAC and to determine oncologic outcomes in this group of patients after ALND or nodal RT or observation.
What is the current status of trial NCT06464341?
This trial is currently completed. The enrollment target is 583 participants. The study started on 2023-05-04. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06464341?
The interventions under investigation include: Observational study no intervention (OTHER).
Who is sponsoring clinical trial NCT06464341?
This trial is sponsored by University Hospital, Basel, Switzerland, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.